- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03452670
Contemplative Well-being Apps for the Workplace
April 9, 2020 updated by: Jennifer Mascaro, Emory University
The study will examine the use and impact of a meditation app delivered to adult workforce populations facing extreme time demands.
Enrollees will be randomized to either app or a wait-list group, and will be assessed in terms of job and daily functioning, well-being, and biomarkers of immune function and stress physiology, and neural structure and function prior to randomization and again at multiple time points after participants commence app engagement.
In order to assess efficacy, we will examine the longitudinal changes in all measures in both the mindfulness group, compared to wait-list control group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Over the last 25 years, research on contemplative practices, a family of practices including mindfulness meditation and yoga, has advanced in domains both clinical and basic, motivated by burgeoning evidence of their efficacy for remediating psychopathology and augmenting well-being and resilience.
However, much of this research has examined the effects of scheduled group interventions, delivered in-person by instructors over the course of several weeks.
Far less research has looked at the delivery method that is most common and arguably most sustainable for busy adults, namely, smart phone delivered Contemplative Applications (apps) for Well-being (CWAs).
The proposed study will examine the use and impact of an app delivered to populations facing extreme time demands.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30329/GA
- Emory University, Wesley Woods Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Emory Healthcare and University employees, Cox Enterprises employees, and Emory students
Exclusion Criteria:
- For students and employees in the biomarker sub-study, participants will be studied only if they pass the Society of Magnetic Resonance Imaging standardized MRI screening protocol (exclusions for ferrous metal in any part of body, such as pacemakers, cochlear implants, surgical clips or metal fragments, serious medical conditions, claustrophobia)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active Group
Participants in this group will use a contemplative wellness application for 8 weeks.
|
Participants will be provided with a contemplative well-being application (CWA) which will facilitate meditation for 10 minutes daily during the 8 week study period.
|
|
Other: Waitlist Group
The waitlist group will receive no intervention during the study but will be able to use the wellness application after completion of the study.
|
The waitlist group will be maintained as a control group throughout all assessments and will be provided enrollment in CWA at the end of the 8 week study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Incivility in Nursing Education Revised Survey score
Time Frame: Baseline, Week 8
|
The Incivility in Nursing Education Revised Survey contains 24-items asking students about behaviors they exhibited or witnessed in the past 12 months (for example, "Students made rude gestures or nonverbal behaviors towards others").
Respondents indicate how often these behaviors occurred by selecting from 1 = Never, 2 = Rarely (only once or twice), 3 = Sometimes (approximately once per month), or 4 = Often (more than once per month).
Total scores can range from 24 to 96, with higher scores indicating more incivility performed or witnessed.
|
Baseline, Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in School-Burnout Inventory score
Time Frame: Baseline, Week 8
|
The School-Burnout Inventory is a 9-item survey asking students about how much burnout they have felt in the past month (for example, "I feel overwhelmed by my schoolwork").
Respondents indicate the degree to which they agree with each statement on a scale of 1 to 6 where 1 = completely disagree and 6 = completely agree.
Total scores can range from 9 to 54, with higher scores indicating more burnout.
|
Baseline, Week 8
|
|
Change in Depression score on the Depression Anxiety and Stress Scale (DASS)
Time Frame: Baseline, Week 8
|
The Depression Anxiety and Stress Scale (DASS) is a 42-item survey asking about feelings of depression and anxiety that the respondent has experienced in the past week (for example, "I found myself getting upset at quite trivial things").
Respondents indicate the degree to which they agree with each statement on a scale of 0 to 3 where 0 = does not apply to me at all and 3 = applied to me very much, or most of the time.
The depression subscale includes 14 items.
A score of 0-9 indicates no depression, 10-13 indicates moderate depression, 14-20 is moderate depression, 21-27 is severe depression and scores of 28 and above indicate extremely severe depression.
|
Baseline, Week 8
|
|
Change in Anxiety score on the Depression Anxiety and Stress Scale (DASS)
Time Frame: Baseline, Week 8
|
The Depression Anxiety and Stress Scale (DASS) is a 42-item survey asking about feelings of depression and anxiety that the respondent has experienced in the past week.
Respondents indicate the degree to which they agree with each statement on a scale of 0 to 3 where 0 = does not apply to me at all and 3 = applied to me very much, or most of the time.
The depression subscale includes 14 items.
A score of 0-7 indicates no anxiety, 8-9 indicates moderate anxiety, 10-14 is moderate anxiety, 15-19 is severe anxiety and scores of 20 and above indicate extremely severe anxiety.
|
Baseline, Week 8
|
|
Change in Empathic Accuracy (EA) Task
Time Frame: Baseline, Week 8
|
The Empathic Accuracy (EA) Task is a dynamic video assessment that asks participants to continuously rate the emotions of others as they tell emotional autobiographical stories.
Empathic accuracy is the correlation between feelings of the story-tellers in the video and what the participants perceive the story-tellers feelings to be.
|
Baseline, Week 8
|
|
Change in gray matter density in the brain stem
Time Frame: Baseline, Week 8
|
The researchers will acquire a high-resolution T1-weighted MRI scan of the whole brain and brain stem from vertex to approximately 2.5 cm below the lower rim of the cerebellum.
Gray matter density in the brain stem, with particular focus on the dorsal motor nucleus of vagus nerve and the nucleus of the solitary tract will be measured.
|
Baseline, Week 8
|
|
Change in white matter density in the brain stem
Time Frame: Baseline, Week 8
|
The researchers will acquire a high-resolution T1-weighted MRI scan of the whole brain and brain stem from vertex to approximately 2.5 cm below the lower rim of the cerebellum.
White matter density in the brain stem, with particular focus on the dorsal motor nucleus of vagus nerve and the nucleus of the solitary tract will be measured.
|
Baseline, Week 8
|
|
Change in Gene (mRNA) expression in peripheral blood mononuclear cells (PBMCs)
Time Frame: Baseline, Week 8
|
Gene (mRNA) expression in PBMCs, focusing on a profile of genes with known involvement in immune function, will be analyzed using the Illumina Human HT-12 BeadArrays.
|
Baseline, Week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 6, 2016
Primary Completion (Actual)
January 15, 2020
Study Completion (Actual)
March 11, 2020
Study Registration Dates
First Submitted
February 13, 2018
First Submitted That Met QC Criteria
February 26, 2018
First Posted (Actual)
March 2, 2018
Study Record Updates
Last Update Posted (Actual)
April 13, 2020
Last Update Submitted That Met QC Criteria
April 9, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00088349
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Active Group
-
University of Sao Paulo General HospitalCompletedSpinal Cord InjuriesBrazil
-
Federal University of PelotasActive, not recruitingFibromyalgia | Fibromyalgia, PrimaryBrazil
-
Université de SherbrookeAlzheimer's Association; Nestle Health ScienceCompleted
-
Institut GuttmannInstituto de Salud Carlos IIICompleted
-
Mackay Medical CollegeNot yet recruitingBehavioral and Psychological Symptoms of Dementia
-
University of ExtremaduraActive, not recruitingOlder Adults, Balance | Postural Balance | Older Adult | Balance AssessmentSpain
-
Joslin Diabetes CenterUniversity of Oklahoma; National Institutes of Health (NIH)RecruitingPhysical Activity | Pregnancy | Exercise | Childhood Obesity | Lactation | Breastfeeding | Childhood Obesity PreventionUnited States
-
Linkoeping UniversitySwedish Athletics AssociationCompleted
-
University of Alabama at BirminghamCompletedSpecific Learning Disability | Mental Health IssueUnited States
-
Hospital San Carlos, MadridInstituto de Salud Carlos IIIRecruitingAtrial Fibrillation (AF) | Ablation Treatment | TerFib_HyerarchySpain